These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 29729533)

  • 1. Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types.
    Kitazawa Y; Jin K; Kakisaka Y; Fujikawa M; Tanaka F; Nakasato N
    Epilepsy Res; 2018 Aug; 144():20-24. PubMed ID: 29729533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up.
    Geithner J; Schneider F; Wang Z; Berneiser J; Herzer R; Kessler C; Runge U
    Epilepsia; 2012 Aug; 53(8):1379-86. PubMed ID: 22686598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management guidelines for children with idiopathic generalized epilepsy.
    Camfield C; Camfield P
    Epilepsia; 2005; 46 Suppl 9():112-6. PubMed ID: 16302884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
    Asadi-Pooya AA; Hashemzehi Z; Emami M
    Seizure; 2014 Nov; 23(10):889-91. PubMed ID: 25189101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
    Cação G; Parra J; Mannan S; Sisodiya SM; Sander JW
    Epilepsy Behav; 2018 May; 82():81-86. PubMed ID: 29602081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
    Wang L; Jiang Z; Chen BB; Wang CT; Wang JX; Bai J; Wang B; Jin L; Zhang WJ; Deng YC; Zhao G; Dang JX; Wang D; Jia SS; Wang TC; Jia FY; Zhang L; Liu YH
    Epilepsy Behav; 2016 Sep; 62():204-8. PubMed ID: 27494356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse after treatment withdrawal of antiepileptic drugs for Juvenile Absence Epilepsy and Juvenile Myoclonic Epilepsy.
    Healy L; Moran M; Singhal S; O'Donoghue MF; Alzoubidi R; Whitehouse WP
    Seizure; 2018 Jul; 59():116-122. PubMed ID: 29807291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in patients with refractory idiopathic generalized epilepsy.
    Gomez-Ibañez A; McLachlan RS; Mirsattari SM; Diosy DC; Burneo JG
    Epilepsy Res; 2017 Feb; 130():69-73. PubMed ID: 28157601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic drug withdrawal in juvenile myoclonic epilepsy.
    Syvertsen M; Fløgstad I; Enger U; Landmark CJ; Koht J
    Acta Neurol Scand; 2019 Feb; 139(2):192-198. PubMed ID: 30378684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizure outcome in 175 patients with juvenile myoclonic epilepsy--a long-term observational study.
    Höfler J; Unterberger I; Dobesberger J; Kuchukhidze G; Walser G; Trinka E
    Epilepsy Res; 2014 Dec; 108(10):1817-24. PubMed ID: 25443450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal interictal epileptiform discharges in idiopathic generalized epilepsy.
    Esmail EH; Nawito AM; Labib DM; Basheer MA
    Neurol Sci; 2016 Jul; 37(7):1071-7. PubMed ID: 26956566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural course and predictors of spontaneous seizure remission in idiopathic generalized epilepsy: 7-27 years of follow-up.
    von Podewils F; Lapp S; Wang ZI; Hartmann U; Herzer R; Kessler C; Runge U
    Epilepsy Res; 2014 Sep; 108(7):1221-7. PubMed ID: 24907182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latencies to first typical generalized spike-wave discharge in idiopathic generalized epilepsies during video-EEG monitoring.
    Oehl B; Götz-Trabert K; Brandt A; Lehmann C; Schulze-Bonhage A
    J Clin Neurophysiol; 2010 Feb; 27(1):1-6. PubMed ID: 20087210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epileptiform asymetries and treatment response in juvenile myoclonic epilepsy.
    Létourneau K; Cieuta-Walti C; Deacon C
    Can J Neurol Sci; 2010 Nov; 37(6):826-30. PubMed ID: 21059546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.
    Welty TE
    Paediatr Drugs; 2006; 8(5):303-10. PubMed ID: 17037947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurophysiology of juvenile myoclonic epilepsy: EEG-based network and graph analysis of the interictal and immediate preictal states.
    Clemens B; Puskás S; Besenyei M; Spisák T; Opposits G; Hollódy K; Fogarasi A; Fekete I; Emri M
    Epilepsy Res; 2013 Oct; 106(3):357-69. PubMed ID: 23886656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
    Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.